Israel’s going to pot
Dubbed “ground zero for cannabis research,” we look at how the £8billion Cannabis industry is transforming medicine and, indeed, recreation in Israel
Cannabis’… The name sends shivers down the spine of Daily Mail readers. While not every Brit foams at the mouth at its very mention, most avoid the ‘c’ word in polite conversation. Not so in Israel. There, cannabis is a wonderful thing. To Israelis, it means a market, industry, innovation, opportunity. They know this plant could transform medicine and recreation in the 21st century, once governments get over themselves and legalise it. And they’re proud to be leading the revolution.
Lawmakers have helped, giving permits and licences. Eight companies can grow cannabis (compared to one in Britain) and restrictions on others doing so have just been lifted. More than 20 start-ups are working on its medical applications, conducting government-approved trials, after universities hand over their work. When something is shown to work, doctors prescribe it, and centres and pharmacies distribute it.
Israel has more than 26,000 patients using cannabis-related drugs (compared to Britain’s six) and this number is expected to be 150,000 in three years (second only to the United States). All the while, Israeli regulators have built a framework (nicknamed ‘the Green Book’) that is the envy of the world. Dr Tamir Gedo, chief executive at BOL Pharma and an industry pioneer, describes it as “20 years ahead of anywhere else”.
Israel’s cannabis ecosystem brings together regulators, patients, doctors, investors, scientists, entrepreneurs, growers, chemists and activists, and the start-up nation – with all its accelerators and incubators – knows how to get safe products quickly to market. There are even specialist recruiters for the industry. Headhunter Jackie Brown says one of the first questions they ask is: “Do you really care about cannabis and its myriad marvellous applications and potential, or do you just think it’s cool to work with weed?”
Dubbed “ground zero for cannabis research,” the land of milk and Mary Jane, Israel now attracts the world’s top marijuana researchers, suppliers and businesses at two annual summits (Cannatech, in March, and Cann10, in September) where talk moves from agriculture to genetics to medicine to commerce.
Exporting Israeli know-how is already well underway. “Israelis [in the cannabis industry] operate everywhere, from Peru to South Africa to Zimbabwe to Macedonia,” says Clifton Flack, co-founder of iCAN: Israel-Cannabis, an investor. “Every country is a link in the chain. Over the next 10 years, a significant percentage of cannabis regulation will be based on Israel’s rules, Israel’s ideology, because it’s so well-developed already. All over the world will be Israeli fingerprints.”
In an estimated £8billion industry, where no-one expects cannabis to remain illegal for recreational use (four US states already allow it, and 10 more are due to do so next year), the projected figures are jaw-dropping. But it is the plant’s possibilities for medical use – where far more countries approve of its use – that seem almost endless. Doron Ben Ami of Therapix Biosciences says: “Medical cannabis is just starting to flourish. Everyone’s realised it is a valued therapy, including the public. But it’s at an early stage.”
Work actually began more than 50 years ago, when Israeli scientists such as professor Raphael Mechoulam, began isolating and synthesising the psychoactive (THC) and pain-relieving components in cannabis. “The Ministry of Health checked I was trustworthy then gave me 5kg of hashish,” Mechoulam later recalled. “I carried it back [to the lab] on the bus, where everyone could smell it!”
Work since has shown that cannabis can work wonders neurologically too, so it is now known to help treat inflammation, sleep disorders, indigestion, nausea and stress, to name but a few, with trials showing promising results for colitis, Crohn’s, dementia, Parkinson’s, tinnitus, dystonia and spasticity in children with cerebral palsy and epilepsy.
This month, Israeli scientists at BOL began their first cannabis trial on autism, and every day there seems to be a new breakthrough.
At Therapix, trials on patients with Tourette’s and those with early-stage Alzheimer’s are set to begin later this year. In another area, Gedo says one of its treatments (using 300mg of cannabinoids) was recently used in a leukaemia trial of 90 people. “It reduced the rate of rejection in bone marrow transplants from between 30-70 percent down to five. Most people whose bodies reject the transplant die, so this could save many lives. It’s an amazing result. We hope to have the drug in two years.”
All this focuses on Israel’s tiny domestic market, but the real prize is the huge markets outside Israel, in America and Europe, for example.
Ministerial reluctance, together with onerous international rules around production and shipping, has previously meant that Israel’s cannabis has stayed in Israel, but when BOL completes building work next year on (what will be) the world’s largest production facility dedicated to cannabis, that will all change.
With cannabis-related products set to shake up other industries like food supplements, cosmetics and medical devices, experts say the potential is huge. “It is remarkable how a plant is sending shock waves and investment tremors through established industries and ecosystems,” says Flack.
“The opportunities it offers local economies, together with the clear therapeutic and social benefits, are as exciting as they are wide and varied. Cannabis is the next big reason for innovation.”
Thank you for helping to make Jewish News the leading source of news and opinion for the UK Jewish community. Today we're asking for your invaluable help to continue putting our community first in everything we do.
For as little as £5 a month you can help sustain the vital work we do in celebrating and standing up for Jewish life in Britain.
Jewish News holds our community together and keeps us connected. Like a synagogue, it’s where people turn to feel part of something bigger. It also proudly shows the rest of Britain the vibrancy and rich culture of modern Jewish life.
You can make a quick and easy one-off or monthly contribution of £5, £10, £20 or any other sum you’re comfortable with.
100% of your donation will help us continue celebrating our community, in all its dynamic diversity...
Engaging
Being a community platform means so much more than producing a newspaper and website. One of our proudest roles is media partnering with our invaluable charities to amplify the outstanding work they do to help us all.
Celebrating
There’s no shortage of oys in the world but Jewish News takes every opportunity to celebrate the joys too, through projects like Night of Heroes, 40 Under 40 and other compelling countdowns that make the community kvell with pride.
Pioneering
In the first collaboration between media outlets from different faiths, Jewish News worked with British Muslim TV and Church Times to produce a list of young activists leading the way on interfaith understanding.
Campaigning
Royal Mail issued a stamp honouring Holocaust hero Sir Nicholas Winton after a Jewish News campaign attracted more than 100,000 backers. Jewish Newsalso produces special editions of the paper highlighting pressing issues including mental health and Holocaust remembrance.
Easy access
In an age when news is readily accessible, Jewish News provides high-quality content free online and offline, removing any financial barriers to connecting people.
Voice of our community to wider society
The Jewish News team regularly appears on TV, radio and on the pages of the national press to comment on stories about the Jewish community. Easy access to the paper on the streets of London also means Jewish News provides an invaluable window into the community for the country at large.
We hope you agree all this is worth preserving.
